Three-Year Recurrence-Free Survival in Patients With a Very Low Risk of Endometrial Cancer Who Did Not Undergo Lymph Node Dissection (Tree Retro)

2018 ◽  
Vol 28 (6) ◽  
pp. 1123-1129 ◽  
Author(s):  
Miseon Kim ◽  
ChelHun Choi ◽  
Kidong Kim ◽  
Myong Cheol Lim ◽  
Jeong-Yeol Park ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Lymph Node ◽  
Lymph Node Dissection ◽  
Low Risk ◽  
Recurrence Free Survival ◽  
Node Dissection ◽  
Free Survival

Oncological safety and perioperative morbidity in low-risk endometrial cancer with sentinel lymph-node dissection

2019 ◽  
Vol 45 (9) ◽  
pp. 1638-1643 ◽  
Author(s):  
Sara Imboden ◽  
Liliana Mereu ◽  
Franziska Siegenthaler ◽  
Alice Pellegrini ◽  
Andrea Papadia ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Lymph Node Dissection ◽  
Low Risk ◽  
Sentinel Lymph Node Dissection ◽  
Node Dissection ◽  
Perioperative Morbidity ◽  
Oncological Safety

Does Positive Peritoneal Cytology Not Affect the Prognosis for Stage I Uterine Endometrial Cancer?: The Remaining Controversy and Review of the Literature

2014 ◽  
Vol 24 (3) ◽  
pp. 549-555 ◽  
Author(s):  
Takaya Shiozaki ◽  
Tsutomu Tabata ◽  
Tomomi Yamada ◽  
Yuka Yamamoto ◽  
Takaharu Yamawaki ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Lymph Node ◽  
Lymph Node Dissection ◽  
Cox Model ◽  
Stage I ◽  
Small Scale ◽  
Peritoneal Cytology ◽  
Node Dissection ◽  
Free Survival ◽  
Positive Peritoneal Cytology

ObjectiveThe objective of this study was to elucidate factors that affect prognosis in patients with stage I endometrial cancer.MethodsThe study group comprised 265 patients with stage I endometrial cancer treated surgically at either of our facilities between January 1998 and December 2010 (238 patients with negative peritoneal cytology and 27 patients with positive peritoneal cytology). Progression-free survivals were evaluated between the 2 groups, and multivariate analysis was conducted with correlation factors including positive peritoneal cytology, vessel permeation, lymph node dissection, histologic diagnosis, age at diagnosis, adjuvant chemotherapy, and the depth of myometrial invasion.ResultsDisease-free survival was significantly poorer for patients with positive peritoneal cytology than those with negative peritoneal cytology on stage I disease (P = 0.000). The stratified log-rank test with vessel permeation shows the similar results. By univariate Cox model, positive peritoneal cytology, vessel permeation, and systemic lymph node dissection at surgery are significant factors on stage I endometrial cancer.ConclusionsAlthough this is a small-scale preliminary study with adjustment of other factors, positive peritoneal cytology can contribute to the risk of progression-free survival in patients with stage I endometrial cancer.

Delay to Inguinal Lymph Node Dissection Greater than 3 Months Predicts Poorer Recurrence-Free Survival for Patients with Penile Cancer

2017 ◽  
Vol 198 (6) ◽  
pp. 1346-1352 ◽  
Author(s):  
Juan Chipollini ◽  
Dominic H. Tang ◽  
Scott M. Gilbert ◽  
Michael A. Poch ◽  
Julio M. Pow-Sang ◽  
...  
Keyword(s):  
Lymph Node ◽  
Lymph Node Dissection ◽  
Penile Cancer ◽  
Inguinal Lymph Node ◽  
Recurrence Free Survival ◽  
Node Dissection ◽  
Inguinal Lymph Node Dissection ◽  
Free Survival

PELVIC LYMPH NODE DISSECTION SHOULD BE OMITTED IN LOW RISK PROSTATE CANCER PATIENTS. RESULTS OF A MATCHED ANALYSIS

2009 ◽  
Vol 181 (4S) ◽  
pp. 756-757
Author(s):  
Alberto Briganti ◽  
Alexander Haese ◽  
Umberto Capitanio ◽  
Andrea Gallina ◽  
Felix K h Chun ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Lymph Node ◽  
Cancer Patients ◽  
Lymph Node Dissection ◽  
Pelvic Lymph Node Dissection ◽  
Low Risk ◽  
Pelvic Lymph Node ◽  
Node Dissection ◽  
Risk Prostate Cancer ◽  
Low Risk Prostate Cancer
Sign in / Sign up

Export Citation Format

Share Document